Bull Of The Day: Herbalife (HLF)

Herbalife (HLF) is highlighted as a Zacks Rank #1 (Strong Buy) due to its strong value rating and recent positive earnings surprises, averaging 133% over the last year, with the most recent quarter showing a 47.5% surprise. Earnings estimates for 2025 have risen from $1.74 to $1.91 over the last 30 days, and 2026 estimates also saw an increase, alongside improving margins over the last three quarters. The company's low forward PE of 3.5x and price-to-sales ratio of 0.14x suggest potential undervaluation if revenue growth continues.

Analysis

Herbalife (HLF) currently presents a compelling case, designated as a Zacks Rank #1 (Strong Buy) with an 'A' for Value, despite a 'D' for Growth. The company's financial performance has been robust, evidenced by four consecutive beats of the Zacks Consensus Estimate, culminating in an average positive earnings surprise of 133% over the last year. Specifically, the most recent earnings report showcased a 47.5% surprise, with earnings per share (EPS) at $0.59 compared to the consensus of $0.40. Analyst sentiment is strengthening, with full-year 2025 EPS estimates revised upwards from $1.74 to $1.91 over the past 30 days, and 2026 estimates increasing from $2.26 to $2.30. Valuation metrics appear attractive; HLF trades at a forward P/E ratio of 3.5x, which the article deems reasonable given a recent growth contraction, and a price-to-sales ratio of 0.14x, which could indicate undervaluation if revenue growth solidifies. Furthermore, operational efficiency is improving, as demonstrated by rising margins over the last three quarters, progressing from 3.8% to 4.0% and then to 4.23% in the most recent quarter.

Key Decisions for Investors

• Investors could consider Herbalife's shares given its Strong Buy rating, consistent earnings outperformance, positive analyst estimate revisions, and notably low valuation metrics such as the 3.5x forward P/E.
• It is crucial to monitor the company's ability to translate operational improvements into sustained revenue growth, particularly to address the recent growth contraction and the 'D' grade for Growth, which will be key for the 0.14x price-to-sales ratio to reflect true undervaluation.
• Continued margin expansion and further upward revisions in earnings estimates would serve as strong confirmatory signals for the positive investment thesis.